NKTR: clinical update presentation

https://finance.yahoo.com/news/first-data-nktr-214-combinati…

NKTR presented some interim clinical data in an oral presentation over the weekend. It’s a clinical trial that is a combination IO therapy with a BMS drug.

Very positive.

Safety data looks great on a few dozen patients

Efficacy in some patients with a possible complete response of o Stage 4 patient

Results included 3 types of cancer

Expanding trial to include 5 cancer types and 330 patients (I think the trial had only 38 patients before)

Stock up another 25% in premarket trading after being up significantly last week

Unfortunately it’s still my smallest of my 10 positions

Chris

10 Likes

Nektar Therapeutics: Encouraging Data Revealed At SITC $NKTR http://www.seekingalpha.com/article/4124012

A good SA article that summarizes NKTR clinical results.

Hi Chris, what caused you to investigate NKTR?

Unfortunately it’s still my smallest of my 10 positions

This is because your other stocks are also going up like mad :slight_smile:

Hi Chris, what caused you to investigate NKTR?

A friend owns it and he told me about that company and what they are doing. I then did my own research. Actually, he told me about several other companies too but I only bought NKTR.

Chris

2 Likes

This is because your other stocks are also going up like mad :slight_smile:

Haha. It is true that my other stocks are going up, but since I bought NKTR, NKTR has gone up more (percentage-wise) than all the others. I bought NKTR at $18.97, $20.35, and $22.00. My average cost basis is $20.45 so my gain is about 81% in less than 3 months.

Chris

1 Like

I bought NKTR at $18.97, $20.35, and $22.00. My average cost basis is $20.45 so my gain is about 81% in less than 3 months.

Wow, this is unbelievable. Congratulations!